Is chemotherapy beneficial? A retrospective study of chemotherapy in patients with invasive intraductal papillary-mucinous carcinoma
Chemotherapy is an independent protective factor IPMC, especially reducing the risk of short-term death for IPMC patients with lymph node metastasis.
Authors
- Yonghao Ouyang
- Hong‐Jian Zhu (ORCID: https://orcid.org/0000-0002-1478-995X)
- Yi Xiao (ORCID: https://orcid.org/0000-0002-3817-3471)
- Pengpeng Liu (ORCID: https://orcid.org/0000-0002-5148-4653)
- Caihua Zhang (ORCID: https://orcid.org/0000-0002-7457-2816)
- Qiang Hao
- Lihua Chu
Institutions
- Jinggangshan University (CN)
- Xuzhou Central Hospital (CN)
- Jinling Institute of Technology (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e38430
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00